Stockscreener 앱 받기
0.98
7.54%
0.0687
시장 영업 전:
.96
-0.02
-2.04%
전일 마감가:
$0.9113
열려 있는:
$0.91
하루 거래량:
491.50K
Relative Volume:
4.30
시가총액:
$8.92M
수익:
$9.19M
순이익/손실:
$-6.94M
주가수익비율:
-1.1783
EPS:
-0.8317
순현금흐름:
$-7.57M
1주 성능:
+1.93%
1개월 성능:
-26.87%
6개월 성능:
-79.37%
1년 성능:
-79.46%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.8901
$1.05
52주 변동 폭
$0.8901
$6.12
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
명칭
Neuroone Medical Technologies Corp
전화
(952) 426-1383
주소
7599 ANAGRAM DR, EDEN PRAIRIE
Compare NMTC vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NMTC
Neuroone Medical Technologies Corp
|
0.98 | 8.92M | 9.19M | -6.94M | -7.57M | -0.8317 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-05 | 개시 | Ladenburg Thalmann | Buy |
| 2022-03-29 | 다운그레이드 | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp 주식(NMTC)의 최신 뉴스
Saba Capital Income & Opportunities Fund II (SABA) Stock Price, News, Quote & History - Yahoo! Finance Canada
OneMedNet Corporation Announces 1-for-10 Reverse Stock Split - Yahoo Finance
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
NeuroOne at Moody Capital conference: thin-film platform aims for growth - Investing.com
NeuroOne at Moody Capital conference: thin-film platform aims for growth - Investing.com UK
NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com Australia
NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com Nigeria
NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com
NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com India
NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com
NeuroOne Medical (NMTC) exec buys shares and receives 35,000 options - Stock Titan
NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com South Africa
BioRestorative Therapies Announces Reverse Stock Split - Yahoo Finance
NeuroOne (NMTC) CFO gets 35,000 options at $1.77 - Stock Titan
NeuroOne (NMTC) grants officer options at $1.77 - Stock Titan
Neuroone Medical Technologies Corp (NASDAQ: NMTC) Stock Price, News & Analysis - kalkine.ca
NeuroOne Medical (NMTC) grants CTO 15,000 options vesting from 2027 - Stock Titan
NeuroOne Medical (NMTC) CEO granted 68K stock options - Stock Titan
NeuroOne Medical (NMTC) CAO awarded 12,500 stock options - Stock Titan
NeuroOne Medical | 4: Statement of changes in beneficial ownership of securities-Officer Rosa David A - Moomoo
Neuroone Medical Technologies Corp (NMTC) Key Financial Ratios – Valuation, Profitability & More - Value Research
NeuroOne Expects First StereoCED Revenue in Current Quarter - minichart.com.sg
NeuroOne reports successful large-animal StereoCED procedures, expects related revenue in Q4 2026 - TradingView
NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform - Yahoo Finance
NeuroOne (NMTC) Q3 2026 Earnings Call Transcript - The Globe and Mail
JonesTrading Maintains NeuroOne Medical(NMTC.US) With Buy Rating, Maintains Target Price $8 - Moomoo
NeuroOne Medical Technologies (NasdaqCM:NMTC) Stock Forecast & Analyst Predictions - Simply Wall Street
NeuroOne Medical Technologies Corp (NMTC) (Q3 2026) Earnings Cal - GuruFocus
Neuroone Medical earnings missed by $0.10, revenue fell short of estimates - Investing.com
NMTC Maintained by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
NeuroOne (NMTC) Earnings Call zum 3. Quartal des Geschäftsjahres 2026: Aufträge steigen um 43 %, Marge erreicht 59,9 % - TradingKey
Nerdy Inc. Announces 1-For-15 Reverse Stock Split - Yahoo Finance
NeuroOne Medical Technologies Corporation Q3 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: NeuroOne Medical posts Q3 2026 revenue growth as shares fall - Investing.com
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Australia
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Nigeria
Is NeuroOne Medical Technologies Corp (NMTC) Positioned for Grow - GuruFocus
NEUROONE MEDICAL TECHNOLOGIES Corp 3Q FY2026: Revenue $1.97M, EPS $(0.28) — 10-Q Summary - TradingView
Q3 2026 NeuroOne Medical Technologies Corp Earnings Call Transcript - GuruFocus
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Canada
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com India
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com UK
NeuroOne posts Q3 FY2026 revenue up 16% to $2.0M; gross margin expands to 59.9% - TradingView
NeuroOne Medical Technologies (NASDAQ: NMTC) posts larger loss and flags going concern risk - Stock Titan
NeuroOne Fiscal Q3 2026 Earnings: Gross Margin Expands as Net Loss Widens - TradingKey
NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% - Yahoo Finance
NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% - The Globe and Mail
NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification - Yahoo Finance
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time - finance.yahoo.com
Neuroone Medical Technologies Corp (NMTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Neuroone Medical Technologies Corp 주식 (NMTC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Christianson Mark | Market Development Director |
Jun 30 '26 |
Sale |
3.18 |
10,000 |
31,773 |
20,692 |
| Christianson Mark | Officer |
Jun 30 '26 |
Proposed Sale |
3.34 |
10,000 |
33,400 |
0 |
| Christianson Mark | Business Development Director |
Mar 30 '26 |
Sale |
0.74 |
15,363 |
11,369 |
198,920 |
| Christianson Mark | Business Development Director |
Mar 13 '26 |
Sale |
0.80 |
100 |
80 |
214,283 |
| Christianson Mark | Business Development Director |
Mar 12 '26 |
Sale |
0.80 |
817 |
654 |
214,383 |
| Christianson Mark | Business Development Director |
Mar 11 '26 |
Sale |
0.80 |
2,109 |
1,687 |
215,200 |
| Christianson Mark | Business Development Director |
Mar 10 '26 |
Sale |
0.80 |
11,611 |
9,289 |
217,309 |
| Christianson Mark | Officer |
Mar 09 '26 |
Proposed Sale |
0.84 |
30,000 |
25,200 |
0 |
| Wambeke David J. | Chief Business Officer |
Mar 01 '26 |
Buy |
0.67 |
1,000,000 |
670,400 |
1,000,000 |
1.75%
1.62%
자본화:
|
볼륨(24시간):